Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy

Éric Ravussin, Steven R. Smith, Julie A. Mitchell, +5

Obesity

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, +17

The Lancet

Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study

Anna I. Guerdjikova, Brandon Walsh, Kevin Shan, +3

Advances in Therapy

Method‐of‐use study of naltrexone sustained release (<scp>SR</scp>)/bupropion <scp>SR</scp> on body weight in individuals with obesity

Amy E. Halseth, Kevin Shan, Brandon Walsh, +2

Obesity

Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion

Amy E. Halseth, Kevin Shan, Kye Gilder, +2

Obesity Science & Practice

Pramlintide Improved Measures of Glycemic Control and Body Weight in Patients With Type I Diabetes Mellitus Undergoing Continuous Subcutaneous Insulin Infusion Therapy

Kathrin Herrmann, Juan P. Frías, Steven V. Edelman, +5

Postgraduate Medicine

Analogical Framing: How Policy Comparisons Alter Political Support for Health Care Reform

Jason Barabas, Benjamin Carter, Kevin Shan

American Politics Research

Generative artificial intelligence versus clinicians: Who diagnoses multiple sclerosis faster and with greater accuracy?

Mahi A. Patel, Francisco J. Villalobos, Kevin Shan, +10

Multiple Sclerosis and Related Disorders

Association of Blood Pressure With Brain White Matter Microstructural Integrity Assessed With MRI Diffusion Tensor Imaging in Healthy Young Adults

Junyeon Won, Pauline Maillard, Kevin Shan, +4

Hypertension